FR3013049B1 - ANALOGUE OF INSULIN GLARGINE - Google Patents

ANALOGUE OF INSULIN GLARGINE

Info

Publication number
FR3013049B1
FR3013049B1 FR1361127A FR1361127A FR3013049B1 FR 3013049 B1 FR3013049 B1 FR 3013049B1 FR 1361127 A FR1361127 A FR 1361127A FR 1361127 A FR1361127 A FR 1361127A FR 3013049 B1 FR3013049 B1 FR 3013049B1
Authority
FR
France
Prior art keywords
analogue
insulin glargine
glargine
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1361127A
Other languages
French (fr)
Other versions
FR3013049A1 (en
Inventor
Corine Vialas
Maximilien Blas
You-Ping Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1361127A priority Critical patent/FR3013049B1/en
Priority to PCT/EP2014/074508 priority patent/WO2015071368A1/en
Publication of FR3013049A1 publication Critical patent/FR3013049A1/en
Application granted granted Critical
Publication of FR3013049B1 publication Critical patent/FR3013049B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR1361127A 2013-11-14 2013-11-14 ANALOGUE OF INSULIN GLARGINE Expired - Fee Related FR3013049B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1361127A FR3013049B1 (en) 2013-11-14 2013-11-14 ANALOGUE OF INSULIN GLARGINE
PCT/EP2014/074508 WO2015071368A1 (en) 2013-11-14 2014-11-13 Long-acting insulin glargine analogue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1361127A FR3013049B1 (en) 2013-11-14 2013-11-14 ANALOGUE OF INSULIN GLARGINE

Publications (2)

Publication Number Publication Date
FR3013049A1 FR3013049A1 (en) 2015-05-15
FR3013049B1 true FR3013049B1 (en) 2015-11-13

Family

ID=50482902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1361127A Expired - Fee Related FR3013049B1 (en) 2013-11-14 2013-11-14 ANALOGUE OF INSULIN GLARGINE

Country Status (2)

Country Link
FR (1) FR3013049B1 (en)
WO (1) WO2015071368A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2571857C2 (en) 2008-03-18 2015-12-20 Ново Нордиск А/С Acylated insulin analogues stabilised with respect to proteases
TWI700091B (en) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 Insulin containing pharmaceutical compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646242A (en) 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
US5656772A (en) 1996-07-19 1997-08-12 Markel; Philip A. Gas pressure gauge clamp
DE59711533D1 (en) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulin derivatives with increased zinc binding
DE19825447A1 (en) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh New insulin analogues with increased zinc formation
EP1545460A4 (en) 2001-12-20 2005-11-16 Lilly Co Eli Insulin molecule having protracted time action
WO2004096854A2 (en) * 2003-04-29 2004-11-11 Eli Lilly And Company Insulin analogs having protracted time action
PL2107069T3 (en) 2003-08-05 2013-06-28 Novo Nordisk As Novel insulin derivatives
WO2006008238A1 (en) * 2004-07-16 2006-01-26 Novo Nordisk A/S Method for selective acylation
ES2490243T3 (en) * 2005-02-02 2014-09-03 Novo Nordisk A/S Insulin derivatives
ES2542146T3 (en) * 2006-07-31 2015-07-31 Novo Nordisk A/S PEGylated extended insulin.
US20120214965A1 (en) 2011-02-23 2012-08-23 Elona Biotechnologies Glargine proinsulin and methods of producing glargine insulin analogs therefrom
MX2010001645A (en) * 2007-08-15 2010-03-10 Novo Nordisk As Insulin analogues with an acyl and aklylene glycol moiety.
MY161892A (en) 2008-02-19 2017-05-15 Biocon Ltd A method of obtaining a purified, biologically active heterologous protein

Also Published As

Publication number Publication date
WO2015071368A1 (en) 2015-05-21
FR3013049A1 (en) 2015-05-15

Similar Documents

Publication Publication Date Title
DK2963056T3 (en) INSULIN ANALOGUE AND APPLICATION THEREOF
DK3057983T3 (en) Glucagon analogs
CL2015003031A1 (en) Peptide compound
DK3587448T3 (en) HETERODIMER PROTEINS
UA29014S (en) COMPUTER
BR302014000346S1 (en) Configuration applied to eyeglass components
DK3590566T3 (en) BODY CARRIED INJECTOR
DK3027249T3 (en) INJECTION PEN
DK3088054T3 (en) Ball
DK3000133T3 (en) PIEZOELECTRIC SENSOR
UA29750S (en) INHALER
FR3013049B1 (en) ANALOGUE OF INSULIN GLARGINE
DK2983690T3 (en) Neuropeptide Y-derived peptides
FR3005989B1 (en) AIRCRAFT TURBOPROPOWER
DE112014003851A5 (en) sensor assembly
FR3004919B1 (en) IMPROVEMENT TO EXTERNAL FIXATORS
FR3007801B1 (en) INJECTION ELEMENT
DE112014002244A5 (en) infusion
BR302014002438S1 (en) Configuration applied to an inhaler
BR302014002245S1 (en) Configuration applied to an inhaler
BR302014002246S1 (en) Configuration applied to an inhaler
FR3008725B1 (en) FUNERAL MONUMENT
TH1401007267A (en) Angular sensor
UA27471S (en) INSULIN INJECTOR MEDICAL
TH1401007105A (en) Syringe (Syringe)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20200910